investors.vrtx.comInvestor Relations | Vertex Pharmaceuticals
investors.vrtx.com Profile
Investors.vrtx.com is a subdomain of vrtx.com,
which was created on 2000-01-08,making it 24 years ago.
It has several subdomains, such as careers.vrtx.com , among others.
Description：The Investor Relations website contains information about Vertex Pharmaceuticals's business for stockholders, potential investors, and financial...
Discover investors.vrtx.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
investors.vrtx.com Information
| HomePage size: 63.09 KB |
| Page Load Time: 0.645148 Seconds |
| Website IP Address: 199.239.182.58 |
investors.vrtx.com Similar Website
| Vertex Blog - Vertex School - AAA Mentors - 100% Virtual |
| Masonite International Corp. - Investor Relations - Investor Relations |
| Block, Inc. (SQ) Investor Relations - Investor Relations |
| Gen Investor Relations - Investor Relations |
| MindChamps PreSchool Limited - Investor Relations: Investor Relations |
| Home - Ayala Land Investor Relations : Ayala Land Investor Relations |
| Universal Technical Institute's Investor Relations - UTI Investor Relations |
| Ameriprise Financial Investor Relations | Investor Relations |
| Meridian Bank Investor Relations - Meridian Bank Investor Relations |
| Armstrong World Industries Investor Relations | Armstrong Flooring Investor Relations |
| Vertex Pharmaceuticals | Careers |
| Vertex BD Building Design Software by Vertex Systems - Argos Systems, Inc. |
investors.vrtx.com PopUrls
| Investor Relations | Vertex Pharmaceuticals https://investors.vrtx.com/ |
| Email Alerts - Unsubscribe https://investors.vrtx.com/unsubscribe |
| 0000875320-23-000054 | 8-K | XBRL Viewer https://investors.vrtx.com/node/31276/xbrl-viewer |
| IR Contacts https://investors.vrtx.com/contact-us |
| Investor Feedback https://investors.vrtx.com/investor-feedback |
| Vertex Announces Positive Results From Phase 2 Study of ... https://investors.vrtx.com/node/29041 |
| FAQs https://investors.vrtx.com/investor-faqs |
| SC 13G https://investors.vrtx.com/node/30131/html |
| Positive Phase 3 Study Results for TRIKAFTA® ( ... https://investors.vrtx.com/node/27601/pdf |
| Press Releases | Vertex Pharmaceuticals https://investors.vrtx.com/press-releases |
| Quarterly Results | Vertex Pharmaceuticals https://investors.vrtx.com/financial-information/quarterly-results |
| Vertex Reports Fourth Quarter and Full Year Financial 2022 Results ... https://investors.vrtx.com/news-releases/news-release-details/vertex-reports-fourth-quarter-and-full-year-financial-2022 |
| Events & Presentations | Vertex Pharmaceuticals https://investors.vrtx.com/events-presentations |
| Vertex Reports Fourth Quarter and Full Year 2023 Financial Results ... https://investors.vrtx.com/news-releases/news-release-details/vertex-reports-fourth-quarter-and-full-year-2023-financial |
| Vertex Provides Pipeline and Business Updates in Advance of Upcoming ... https://investors.vrtx.com/news-releases/news-release-details/vertex-provides-pipeline-and-business-updates-advance-upcoming |
investors.vrtx.com Httpheader
| Accept-Ranges: bytes |
| Content-Encoding: gzip |
| Content-Language: en |
| Content-Type: text/html; charset=UTF-8 |
| device: desktop |
| ETag: "1589309350" |
| Expect-CT: max-age=0, report-uri="/report-expect-ct-violation" |
| Feature-Policy: "accelerometer none;ambient-light-sensor none;autoplay self;camera none;encrypted-media none;fullscreen self;geolocation self;gyroscope none;magnetometer none;microphone none;midi none;payment none;picture-in-picture none;speaker self;sync-xhr self;usb none;vibrate none;vr none", From-Origin: same |
| Last-Modified: Tue, 12 May 2020 18:49:10 GMT |
| Link: http://investors.vrtx.com/; rel="shortlink", http://investors.vrtx.com/; rel="canonical", https://investors.vrtx.com/investor-relations; rel="alternate"; hreflang="en", https://investors.vrtx.com/investor-relations; rel="revision" |
| Referrer-Policy: no-referrer-when-downgrade |
| Server: nginx |
| X-Age: 713 |
| X-Cache-Hits: 2 |
| X-Content-Type-Options: nosniff |
| X-Drupal-Dynamic-Cache: UNCACHEABLE |
| X-Frame-Options: SAMEORIGIN |
| X-Generator: Drupal 8 (https://www.drupal.org) |
| X-Request-ID: v-43f856a2-9481-11ea-bdfd-8be07d718a81 |
| X-UA-Compatible: IE=edge |
| X-XSS-Protection: 1; mode=block |
| X-EdgeConnect-MidMile-RTT: 63 |
| X-EdgeConnect-Origin-MEX-Latency: 8 |
| X-Akamai-Transformed: 9 12677 0 pmb=mRUM,1 |
| Cache-Control: public, max-age=0, s-maxage=1800 |
| Expires: Tue, 12 May 2020 19:01:03 GMT |
| Date: Tue, 12 May 2020 19:01:03 GMT |
| Content-Length: 13019 |
| Connection: keep-alive |
| Vary: Accept-Encoding |
| Set-Cookie: DrupalVisitorMobile=0; path=/; Secure; HttpOnly |
| Strict-Transport-Security: max-age=15768000 ; preload |
investors.vrtx.com Meta Info
| charset="utf-8"/ |
| content="Investor Relations | Vertex Pharmaceuticals" name="title"/ |
| content="Vertex Pharmaceuticals" property="og:site_name"/ |
| content="website" property="og:type"/ |
| content="The Investor Relations website contains information about Vertex Pharmaceuticals's business for stockholders, potential investors, and financial analysts." name="description"/ |
| content="https://investors.vrtx.com/investor-relations" property="og:url"/ |
| content="Investor Relations | Vertex Pharmaceuticals" property="og:title"/ |
| content="no-referrer" name="referrer"/ |
| content="The Investor Relations website contains information about Vertex Pharmaceuticals's business for stockholders, potential investors, and financial analysts." property="og:description"/ |
| content="Drupal 8 (https://www.drupal.org)" name="Generator"/ |
| content="width" name="MobileOptimized"/ |
| content="true" name="HandheldFriendly"/ |
| content="width=device-width, initial-scale=1.0" name="viewport"/ |
investors.vrtx.com Ip Information
| Ip Country: United States |
| Latitude: 37.751 |
| Longitude: -97.822 |
investors.vrtx.com Html To Plain Text
Investor Relations Investors Home News & Events Press Releases Events & Presentations Stock Information Quote & Chart Historic Stock Lookup Investment Calculator Analyst Coverage Financial Information SEC Filings Quarterly Results Corporate Governance Governance Documents Leadership Board of Directors Investor Resources IR Contacts FAQs Approved Medicines Pipeline NASDAQ: VRTX Price Change Copyright West LLC. Minimum 15 minutes delayed. Investor Relations Site - Hero Circle Menu Leadership Team Research Pipeline Corporate Responsibility Featured Videos Investor Relations Events & Presentations Apr 29 2020 at 5:00 PM EDT Apr 29 2020 at 5:00 PM EDT Vertex Pharmaceuticals First Quarter 2020 Earnings Conference Call Read More Jan 30 2020 at 4:30 PM EST Jan 30 2020 at 4:30 PM EST Vertex Pharmaceuticals Fourth Quarter 2019 Earnings Conference Call Read More Jan 14 2020 at 11:30 PM PST Jan 14 2020 at 11:30 PM PST 38th Annual J.P. Morgan Healthcare Conference Read More View All Latest Press Releases May 11 2020 CRISPR Therapeutics and Vertex Pharmaceuticals Announce FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to CTX001™ for the Treatment of Severe Hemoglobinopathies Read More May 01 2020 Vertex Receives European CHMP Positive Opinion for KALYDECO® (ivacaftor) for Children and Adolescents With Cystic Fibrosis Between the Ages 6 Months and 18 Years With the R117H Mutation in the CFTR Gene Read More Apr 29 2020 Vertex Reports First-Quarter 2020 Financial Results Read More View All Stock Graph Copyright West LLC. Minimum 15 minutes delayed. View More IR Contacts Institutional Analyst and Financial Analysts, please contact: Michael Partridge Senior Vice President, Investor Relations +1(617)-341-6108 Zach Barber Senior Director, Investor Relations +1(617)-341-6470 Brenda Eustace Director, Investor Relations +1(617)-341-6187 Main Info Investorinfo@VRTX.com +1(617)-961-7163 Contacting Vertex’s Transfer Agent Communication regarding transfer requirements, lost certificates and changes of address should be directed to: Computershare Investor Services P.O. Box 43023 Providence, RI 02940-3023 Telephone: +1(781)-575-2879 Fax: +1(781)-575-3605 Footer Col 1 News & Events Stock Information Analyst Coverage Footer Col 2 Financial Information Corporate Governance Investor Resources Footer Col 3 Vertex Global Sites Great Britain France Germany Social Media Footer Bottom Privacy Policy Terms of Use Compliance Training Transparency Copyright ©...
investors.vrtx.com Whois
Domain Name: VRTX.COM Registry Domain ID: 16852672_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.corporatedomains.com Registrar URL: http://cscdbs.com Updated Date: 2024-01-04T06:04:46Z Creation Date: 2000-01-08T07:10:25Z Registry Expiry Date: 2025-01-08T07:10:25Z Registrar: CSC Corporate Domains, Inc. Registrar IANA ID: 299 Registrar Abuse Contact Email: domainabuse@cscglobal.com Registrar Abuse Contact Phone: 8887802723 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: EXT-NS1-BOS.VRTX.COM Name Server: EXT-NS1-SD.VRTX.COM DNSSEC: unsigned >>> Last update of whois database: 2024-05-17T20:11:10Z <<<